BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 10996734)

  • 1. p53 Is Not Required for High CIN to Induce Tumor Suppression.
    Funk LC; Wan J; Ryan SD; Kaur C; Sullivan R; Roopra A; Weaver BA
    Mol Cancer Res; 2021 Jan; 19(1):112-123. PubMed ID: 32948674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misaligned Chromosomes are a Major Source of Chromosomal Instability in Breast Cancer.
    Tucker JB; Bonema SC; García-Varela R; Denu RA; Hu Y; McGregor SM; Burkard ME; Weaver BA
    Cancer Res Commun; 2023 Jan; 3(1):54-65. PubMed ID: 36968230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer.
    Liu C; Srihari S; Lal S; Gautier B; Simpson PT; Khanna KK; Ragan MA; Lê Cao KA
    Mol Oncol; 2016 Jan; 10(1):179-93. PubMed ID: 26456802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generating chromosome instability through the simultaneous deletion of Mad2 and p53.
    Burds AA; Lutum AS; Sorger PK
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11296-301. PubMed ID: 16055552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies.
    Obermiller PS; Tait DL; Holt JT
    Breast Cancer Res; 2000; 2(1):28-31. PubMed ID: 11250690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines.
    Regenbrecht CR; Jung M; Lehrach H; Adjaye J
    BMC Med Genomics; 2008 Oct; 1():49. PubMed ID: 18847459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How do tumors make ends meet?
    Lengauer C
    Proc Natl Acad Sci U S A; 2001 Oct; 98(22):12331-3. PubMed ID: 11675484
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics.
    Egawa C; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Jpn J Cancer Res; 2001 Jun; 92(6):624-30. PubMed ID: 11429050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53, BRCA1 and breast Cancer chemoresistance.
    Scata KA; El-Deiry WS
    Adv Exp Med Biol; 2007; 608():70-86. PubMed ID: 17993233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Implications of Chromosomal Instability (CIN) and Kinetochore Abnormalities in Breast Cancers.
    Voutsadakis IA
    Mol Diagn Ther; 2019 Dec; 23(6):707-721. PubMed ID: 31372940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers.
    Miyoshi Y; Iwao K; Takahashi Y; Egawa C; Noguchi S
    Cancer Lett; 2000 Oct; 159(2):211-6. PubMed ID: 10996734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acceleration of chromosomal instability of BRCA1-associated hereditary breast cancers by p53 abnormality.
    Miyoshi Y; Iwao K; Ikeda N; Egawa C; Noguchi S
    Breast J; 2002; 8(2):77-80. PubMed ID: 11896751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations.
    Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA
    Breast Cancer Res Treat; 2003 Nov; 82(1):1-9. PubMed ID: 14672397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations.
    Phillips KA; Nichol K; Ozcelik H; Knight J; Done SJ; Goodwin PJ; Andrulis IL
    J Natl Cancer Inst; 1999 Mar; 91(5):469-73. PubMed ID: 10070948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.
    Focken T; Steinemann D; Skawran B; Hofmann W; Ahrens P; Arnold N; Kroll P; Kreipe H; Schlegelberger B; Gadzicki D
    Cytogenet Genome Res; 2011; 135(2):84-92. PubMed ID: 22024613
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.